SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-21-000080
Filing Date
2021-07-02
Accepted
2021-07-02 11:54:00
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162524122536579.html 4  
1 FORM 4 wf-form4_162524122536579.xml 4 3881
  Complete submission text file 0001457612-21-000080.txt   5363
Mailing Address C/O MILLENNIUM PHARMACEUTICALS INC 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
BATE KENNETH (Reporting) CIK: 0001210238 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 211068639

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)